YCBD cbdMD Inc

Price (delayed)

$0.601

Market cap

$2.33M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$12.24

Enterprise value

$5.97M

cbdMD, Inc. is one of the world’s leading, most highly trusted health & wellness CBD companies, whose current products include CBD tinctures, CBD capsules, CBD gummies, CBD topicals, CBD botanical ...

Highlights
The EPS has soared by 71% year-on-year and by 3.1% since the previous quarter
The net income has soared by 58% YoY but it has decreased by 8% QoQ
YCBD's equity has dropped by 88% year-on-year and by 56% since the previous quarter
The company's debt has surged by 71% QoQ and by 34% YoY

Key stats

What are the main financial stats of YCBD
Market
Shares outstanding
3.87M
Market cap
$2.33M
Enterprise value
$5.97M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
0.59
Price to sales (P/S)
0.08
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.28
Earnings
Revenue
$21.58M
EBIT
-$21.64M
EBITDA
-$18.76M
Free cash flow
-$1.72M
Per share
EPS
-$12.24
Free cash flow per share
-$0.58
Book value per share
$1.01
Revenue per share
$7.29
TBVPS
$3.94
Balance sheet
Total assets
$14.55M
Total liabilities
$11.46M
Debt
$5.75M
Equity
$3.09M
Working capital
$473,690
Liquidity
Debt to equity
1.86
Current ratio
1.07
Quick ratio
0.43
Net debt/EBITDA
-0.19
Margins
EBITDA margin
-86.9%
Gross margin
62.7%
Net margin
-100.3%
Operating margin
-91.1%
Efficiency
Return on assets
-130.2%
Return on equity
-228.6%
Return on invested capital
-220.6%
Return on capital employed
-284.2%
Return on sales
-100.3%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

YCBD stock price

How has the cbdMD stock price performed over time
Intraday
-4.6%
1 week
-1.48%
1 month
-1.48%
1 year
-58.55%
YTD
-42.21%
QTD
1.86%

Financial performance

How have cbdMD's revenue and profit performed over time
Revenue
$21.58M
Gross profit
$13.53M
Operating income
-$19.66M
Net income
-$21.65M
Gross margin
62.7%
Net margin
-100.3%
cbdMD's operating income has soared by 64% YoY
The net income has soared by 58% YoY but it has decreased by 8% QoQ
YCBD's operating margin has soared by 52% year-on-year but it is down by 9% since the previous quarter
The company's net margin rose by 44% YoY but it fell by 18% QoQ

Growth

What is cbdMD's growth rate over time

Valuation

What is cbdMD stock price valuation
P/E
N/A
P/B
0.59
P/S
0.08
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.28
The EPS has soared by 71% year-on-year and by 3.1% since the previous quarter
YCBD's equity has dropped by 88% year-on-year and by 56% since the previous quarter
The stock's P/B is 38% below its 5-year quarterly average of 1.0 but 24% above its last 4 quarters average of 0.5
YCBD's P/S is 94% below its 5-year quarterly average of 1.6 and 10% below its last 4 quarters average of 0.1
The revenue has decreased by 25% YoY and by 8% from the previous quarter

Efficiency

How efficient is cbdMD business performance
The company's return on equity has shrunk by 61% QoQ and by 34% YoY
The ROS is up by 44% year-on-year but it is down by 18% since the previous quarter
YCBD's ROIC is up by 35% YoY but it is down by 25% QoQ
The ROA has contracted by 33% from the previous quarter

Dividends

What is YCBD's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for YCBD.

Financial health

How did cbdMD financials performed over time
The total assets is 27% more than the total liabilities
The total assets has plunged by 57% YoY and by 3.6% from the previous quarter
cbdMD's current ratio has shrunk by 51% YoY and by 13% QoQ
The company's debt is 86% higher than its equity
YCBD's equity has dropped by 88% year-on-year and by 56% since the previous quarter
The company's debt has surged by 71% QoQ and by 34% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.